{"altmetric_id":15753330,"counts":{"readers":{"mendeley":19,"citeulike":0,"connotea":0},"total":{"posts_count":2},"policy":{"unique_users_count":1,"unique_users":["nice"],"posts_count":2}},"citation":{"altmetric_jid":"4f6fa4ea3cf058f6100025b1","authors":["David Smelson","David Kalman","Miklos F. Losonczy","Anna Kline","Usha Sambamoorthi","Lauren St. Hill","Kathy Castles-Fonseca","Douglas Ziedonis"],"doi":"10.1007\/s10597-010-9346-9","endpage":"132","first_seen_on":"2017-01-24T21:10:22+00:00","issns":["0010-3853","1573-2789"],"issue":"2","journal":"Community Mental Health Journal","last_mentioned_on":1480464000,"links":["http:\/\/dx.doi.org\/10.1007\/s10597-010-9346-9"],"pdf_url":"http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs10597-010-9346-9.pdf","pmid":"20859765","pubdate":"2010-09-22T00:00:00+00:00","publisher":"Springer US","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Psychology","scheme":"era"},{"name":"Community and Environmental Psychology","scheme":"springer"},{"name":"Medicine & Public Health","scheme":"springer"},{"name":"Psychiatry","scheme":"springer"}],"scopus_subjects":["Social Sciences","Medicine","Health Sciences"],"startpage":"127","subjects":["psychology"],"title":"A Brief Treatment Engagement Intervention for Individuals with Co-occurring Mental Illness and Substance Use Disorders: Results of a Randomized Clinical Trial","type":"article","uri":"http:\/\/link.springer.com\/10.1007\/s10597-010-9346-9","volume":"48","mendeley_url":"http:\/\/www.mendeley.com\/research\/brief-treatment-engagement-intervention-individuals-cooccurring-mental-illness-substance-disorders-r-3"},"altmetric_score":{"score":3,"score_history":{"1y":3,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":7822782,"mean":6.6331385505942,"rank":1917734,"this_scored_higher_than_pct":61,"this_scored_higher_than":4823818,"rank_type":"exact","sample_size":7822782,"percentile":61},"similar_age_3m":{"total_number_of_other_articles":243350,"mean":12.856153696953,"rank":84202,"this_scored_higher_than_pct":63,"this_scored_higher_than":154886,"rank_type":"exact","sample_size":243350,"percentile":63},"this_journal":{"total_number_of_other_articles":604,"mean":3.2095489220564,"rank":109,"this_scored_higher_than_pct":62,"this_scored_higher_than":377,"rank_type":"exact","sample_size":604,"percentile":62},"similar_age_this_journal_3m":{"total_number_of_other_articles":24,"mean":2.504347826087,"rank":6,"this_scored_higher_than_pct":75,"this_scored_higher_than":18,"rank_type":"exact","sample_size":24,"percentile":75}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Librarian":1,"Student  > Doctoral Student":1,"Researcher":5,"Student  > Ph. D. Student":1,"Student  > Postgraduate":1,"Student  > Master":4,"Other":1,"Student  > Bachelor":3,"Professor":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":6,"Social Sciences":2,"Sports and Recreations":2,"Psychology":6,"Agricultural and Biological Sciences":1,"Nursing and Health Professions":1}}}},"posts":{"policy":[{"title":"Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings: Evidence update","url":"https:\/\/www.nice.org.uk\/guidance\/cg120\/evidence\/evidence-update-181548829","license":"public","citation_ids":[15753330,15753330,15753338,4041036,7428025,7428025,1213351,1213351,4041036,15753338,15753330,689308],"posted_on":"2014-11-17T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/cg120\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-923e3485efc11d6049e39c4f6bdc44a89f5133a068339c2a1996093763ef1c70.jpg"}},{"title":"Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings: Appendix A: Summary of new evidence from surveillance","url":"https:\/\/www.nice.org.uk\/guidance\/cg120\/evidence\/appendix-a-summary-of-new-evidence-from-surveillance-2726441822","license":"public","citation_ids":[1194013,1254727,15775028,691414,2478889,15775030,4234903,14029711,2207214,15775039,4041036,7428025,1983613,1011621,1395151,1090568,2164484,2135443,2316896,15775046,15753338,1224154,15775052,15753330,6833173,1329330,4487491,1382951,1517793,15775062,10078198,1792660,2604292,2578965,1216073,2420478,1340268,827774,1843971],"posted_on":"2016-11-30T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/cg120\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-a9947bef23907c731616adadb5f9517fa21ea5bb9139eec568f3e2f54dd96c47.jpg"}}]}}